Advanced Enzyme Technologies has informed that the Security Allotment Committee of the Board of Directors of the Company, at its meeting held today, has approved the allotment of 45,650 Equity Shares of face value of ? 2 per share pursuant to the Exercise of Options under Advanced Enzyme Technologies- Employees Stock Options Scheme (ESOS) 2022. These shares shall rank with the existing equity shares of the Company in all respects. Consequent to the said allotment, the paid-up share capital of the Company stands increased from ? 22,37,62,300 comprising of 11,18,81,150 Equity Shares of ? 2 each to ? 22,38,53,600 comprising of 11,19,26,800 Equity Shares of ? 2 each. The aforesaid intimation is also being uploaded on the website of the Company: www.advancedenzymes.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: